. Dubey, Sttutue d'u taahzoïte gauhe et d'u adzoïte doitee de Toxoplasma gondii, 1998.

, Annexe 4

. Cnr and . De-reims, est composé de quatre pôles répartis sur plusieurs centres hospitaliers, chaque pole étant référent pour des missions spécifiques

A. B. Sabin and H. A. Feldman, Dyes as Microchemical Indicators of a New Immunity Phenomenon Affecting a Protozoon Parasite (Toxoplasma). Science, vol.108, pp.660-663, 1948.

N. D. Levine, J. P. Taxonomy-of-toxoplasma-;-dubey, D. S. Lindsay, and C. A. Speer, Structures of Toxoplasma gondii Tachyzoites, Bradyzoites, and Sporozoites and Biology and Development of Tissue Cysts, Clinical Microbiology Reviews, vol.24, issue.1, pp.267-299, 1977.

J. P. Dubey, Advances in the life cycle of Toxoplasma gondii, International journal for parasitology, vol.28, issue.7, pp.1019-1024, 1998.

J. P. Dubey and J. K. Frenkel, Cyst-induced toxoplasmosis in cats, J Protozool, vol.19, pp.16-17, 1972.

D. J. Ferguson, . Birch-anderson, J. C. Siim, and W. Hutchinson, Observations on the ultrastructure of the sporocyst and the initial of sporozoïte formation in Toxoplasma gondii, Acta Pathol Microbiol, vol.86, pp.165-167, 1978.

U. Gross, M. Holpert, and S. Goebel, Impact of stage differentiation on diagnosis of toxoplasmosis, Ann Ist Super Sanita, vol.40, issue.1, pp.65-70, 2004.

Y. L. Lau and M. Y. Fong, Toxoplasma gondii: serological characterization and immunogenicity of recombinant surface antigen 2 (SAG2) expressed in the yeast Pichia pastoris, Exp Parasitol, vol.119, issue.3, pp.373-381, 2008.

J. L. -jones, D. Kruszon-moran, and M. Wilson, Toxoplasma gondii Prevalence, United States. Emerg Infect Dis, vol.13, pp.656-657, 2007.

J. A. Nicolas and M. Pestre-alexandre, Toxoplasmose : une zoonose transmissible à l'hoe. Med Mal Infect 23 special, pp.129-138, 1993.

L. Baril, T. Ancelle, P. Thulliez, V. Tirard-fleury, and B. Carme, Facteurs de risque d'auisitio de l'hoe, Med Mal Infect, vol.23, pp.129-138

C. Paquet, M. H. Yudin, M. H. Yudin, V. M. Allen, C. Bouchard et al., Toxoplasmosis in Pregnancy: Prevention, Screening, and Treatment, Journal of Obstetrics and Gynaecology Canada. janv, vol.35, issue.1, pp.78-87, 2013.

J. G. Montoya and J. S. Remington, Management of Toxoplasma gondii infection during pregnancy, Clin Infect Dis, vol.47, issue.4, pp.554-66, 2008.

N. Kapaos, B. Favat, V. D'aeoot, and . Fièvre, adénopathie : une situation clinique de toxoplasmose aiguë chez une patiente immunocompétente, Revue Médicale Suisse, vol.5, 2014.

A. M. -tenter, A. R. Heckeroth, and L. M. Weiss, Toxoplasma gondii: from animals to humans, International journal for parasitology, vol.30, pp.1217-1258, 2000.

D. Ajzenberg, L. Balnus, A. Dumetre, M. Demar, B. Carme et al., Genetic diversity, clonality and sexuality in Toxoplasma gondii, Int J Parasitol, vol.34, issue.10, pp.1185-96, 2004.
URL : https://hal.archives-ouvertes.fr/hal-02077121

D. Ajzenberg, I. Lamaury, M. Demar, C. Vautrin, A. Cabié et al., Performance Testing of PCR Assay in Blood Samples for the Diagnosis of Toxoplasmic Encephalitis in AIDS Patients from the French Departments of America and Genetic Diversity of Toxoplasma gondii: A Prospective and Multicentric Study, PLoS Negl Trop Dis, vol.10, issue.6, p.4790, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01503761

M. Demar, N. Elenga, S. Simon, F. Djossou, and B. Carme, Toxoplasmose amazonienne une entité clinique particulière et problématique décrite en Guyane française, p.19

J. C. Boothroyd and J. F. Dubremetz, Kiss and spit: the dual roles of Toxoplasma rhoptries Nat Rev Microbiol, vol.6, pp.79-88, 2008.

L. Sheiner, J. M. Santos, N. Klages, F. Parussini, and N. Jemmely, Toxoplasma gondii Transmembrane microneme proteins and their modular design, Mol Microbiol, 2010.

, Aug, vol.77, issue.4, pp.912-941

B. John, W. Weninger, and C. A. Hunter, Advances in imaging the innate and adaptive immune response to Toxoplasma gondii, Future microbiology, vol.5, issue.9, pp.1321-1328, 2010.

R. T. -gazzinelli, E. Y. Denkers, and A. Sher, Host resistance to Toxoplasma gondii: model for studying the selective induction of cell-mediated immunity by intracellular parasites, Infect Agents Dis, vol.2, issue.3, pp.139-188, 1993.

Y. Suzuki, M. A. Orellana, R. D. Schreiber, and J. S. Remington, Interferon-gamma: the major mediator of resistance against Toxoplasma gondii, Science, vol.240, issue.4851, pp.516-524, 1988.

Y. Suzuki, Host resistance in the brain against Toxoplasma gondii, J Infect Dis, vol.185, issue.1, pp.58-65, 2002.

J. G. Montoya and J. S. Remington, Management of Toxoplasma gondii infection during pregnancy, Clin Infect Dis, vol.47, issue.4, pp.554-66, 2008.

S. Rougier, J. G. Montoya, and F. Peyron, Lifelong Persistence of toxoplasma Cysts: A Questionable Dogma ?, Trends in Parasitology, vol.33, pp.93-101, 2017.

J. E. Kaplan, C. Benson, K. K. Holmes, J. T. Brooks, A. Pau et al., Centers for Disease Control and Prevention (CDC) ; National Institutes of Health ; HIV Medicine 34, Journal of Clinical Microbiology, vol.40, issue.11, pp.4037-4044, 2002.

G. E. Speirs, M. Hakim, R. Y. Calne, and T. G. Wreghitt, Relative risk of donor acquiredToxoplasma gondii in heart, liver and kidney transplantrecipients, Clin transpl, vol.2, pp.257-260, 1988.

D. M. Israelski and R. J. , Toxoplasmosis in the non-AIDS immunocompromised host, Curr Clin Top Infect Dis, vol.13, pp.322-56, 1993.

A. -mele, P. J. Paterson, H. G. Prentice, P. Leoni, and C. C. Kibbler, Toxoplasmosis in bone marrow transplantation: a report of two cases and systematic review of the literature, Bone Marrow Transplant, vol.29, pp.691-699, 2002.

M. -nelson, D. Dockrell, S. Edwards, . Bhiva-guidelines, . Subcommittee et al., British HIV Association and British Infection Association guidelines for the treatment of opportunistic infection in HIV-seropositive individuals, HIV Med. sept, vol.12, issue.2, pp.1-140, 2011.

P. A. Moncada and J. G. Montoya, Toxoplasmosis in the fetus and newborn: an update on prevalence, diagnosis and treatment, Expert Review of Anti-infective Therapy. juill, vol.10, issue.7, pp.815-843, 2012.

V. L. Pereira-chioccola, J. E. Vidal, and C. Su, Toxoplasma gondii infection and cerebral toxoplasmosis in HIV-infected patients, Future Microbiol. déc, vol.4, issue.10, pp.1363-79, 2009.

G. N. Holland, R. E. Engstrom, and B. J. Glasgow, Ocular Toxoplasmosis in Patients with the Acquired Immunodeficiency Syndrome, Am J Ophthalmol, vol.106, pp.653-67, 1988.

I. -cochereau-massin, P. Lehoang, M. Lauthier-frau, L. Zazoun, P. Marcel et al., Efficacy and tolerance of intravitreal ganciclovir in cytomegalovirus retinitis in acquired immune deficiency syndrome, Ophtalmology, vol.98, pp.1348-1355, 1991.

C. -contini, Clinical and diagnostic management of toxoplasmosis in the Immunocompromised patient, Parassitologia. juin, vol.50, issue.1-2, pp.45-50, 2008.

M. Castagnini, S. Bernazzali, C. Ginanneschi, B. Marchi, M. Maccherini et al., Fatal disseminated toxoplasmosis in a cardiac transplantation with seropositive match for Toxoplasma: should prophylaxis be extended?, Transpl Immunol, vol.18, issue.2, pp.193-200, 2007.

F. Kieffer and M. Wallon, Congenital toxoplasmosis, Handb Clin Neurol, vol.112, pp.1099-101, 2013.
URL : https://hal.archives-ouvertes.fr/hal-00390272

P. -garcia-méric, J. Franck, H. Dumon, and R. Piarroux, Management of congenital toxoplasmosis in France, 2010.

G. Desmonts, J. Couveur, and P. Thulliez, Congenital toxoplamosis. 5 cases of mother to child transmission of pre-pregnanacy infection, vol.19, pp.1445-1454, 1990.

C. Chemla, I. Villena, A. D. Hornoy, P. Dupouy, and D. , Preconception seroconversion and maternal seronegativity at delivery do not rule out the risk of congenital toxoplamosis, Clin Diagn Lab immunol, vol.9, issue.2, pp.489-90, 2002.

A. Thomas and P. Mycologie, , 1998.

. 50-freij, . Bj, J. L. Sever, and . Toxoplasmosis, Pediatr Rev, vol.12, issue.8, pp.227-263, 1991.

J. Couvreur and G. Desmonts, A homogeneous series of 210 cases of congénital toxoplasmosis in 0 to 11 month-old infants detected prospectively, Ann Pediatr, vol.31, issue.10, pp.815-824, 1984.

J. -couvreur, Prise en charge et devenir, Med Mal Infect, vol.23, pp.176-182, 1993.

I. -villena and . Cnr-toxoplasmose,

M. Wallon, G. Cozon, R. Ecochard, P. Lewin, and F. Peyron, Serological rebound in congenital toxoplasmosis: long-term follow-up of 133 children, Eur J Pediatr, vol.160, issue.9, pp.534-574, 2001.

J. G. Montoya, Laboratory diagnosis of Toxoplasma gondii infection and toxoplasmosis, J Infect Dis, vol.185, issue.1, pp.73-82, 2002.

H. -fricker-hidalgo, B. Cimon, C. Chemla, M. L. Darde, L. Delhaes et al., Toxoplasma Seroconversion with Negative or Transient Immunoglobulin M in Pregnant Women: Myth or Reality? A French Multicenter Retrospective Study, Journal of Clinical Microbiology, vol.51, issue.7, pp.2103-2111, 2013.

M. H. Bessières, C. Roques, A. Berrebi, V. Barre, M. Cazaux et al., IgA antibody response during acquired and congenital toxoplasmosis, J Clin Pathol, vol.45, issue.7, pp.605-613, 1992.

F. 58-robert-gangneux and M. Dardé, Epidemiology of and Diagnostic Strategies for Toxoplasmosis, Clinical Microbiology Reviews, vol.25, issue.2, pp.264-296, 2012.

S. J. Romand, R. Nobre, and P. Thulliez, Toxoplasmose et grossesse. Medecine thérapeutique/Pediatrie, vol.1, pp.481-489, 1998.

J. G. Montoya, Systematic screening and treatment of toxoplasmosis during pregnancy: is the glass half full or half empty?, Am J Obstet Gynecol, vol.219, issue.4, pp.315-319, 2018.

N. -ferret, M. P. , L. Fichoux, and Y. , , p.61

, Arch Pediatr, vol.10, issue.1, pp.42-46, 2003.

J. L. -burg, C. M. Grover, P. Pouletty, and J. C. Boothroyd, Direct and sensitive detection of a pathogenic protozoan, Toxoplasma gondii, by polymerase chain reaction, Journal of Clinical Microbiology, vol.27, issue.8, pp.1787-1792, 1989.

P. Hohlfeld and J. Macaleese, Fetal toxoplasmosis: ultrasonographic signs, Ultrasound Obstet Gynecol, vol.1, issue.4, pp.241-245, 1991.

S. Romand, M. Wallon, J. Franck, P. Thulliez, F. Peyron et al., Prenatal diagnosis using polymerase chain reaction on amniotic fluid for congenital toxoplasmosis, Obstet Gynecol, vol.97, issue.2, pp.296-300, 2001.

J. M. Costa, P. Ernault, E. Gautier, and S. Bretagne, Prenatal diagnosis of congenital toxoplasmosis by duplex real-time PCR using fluorescence resonance energy transfer hybridization probes, Prenat Diagn, vol.21, issue.2, pp.85-93, 2001.

R. Mcleod, D. Mack, and C. Brown, Toxoplasma gondii--new advances in cellular and molecular biology, Exp Parasitol, vol.72, issue.1, pp.109-130, 1991.

L. Mandelbrot, F. Kieffer, R. Sitta, and H. L. Delmas, Prenatal therapy with pyrimethamine+sulfadiazine vs spiramycin to reduce placental transmission of toxoplasmosis: a multicenter
URL : https://hal.archives-ouvertes.fr/hal-01987714

D. -filisetti, M. Brenier-pinchart, and Y. Sterkers, Logigramme associé aux « Recommandations destinées aux professionnels de santé concernant le diagnostic par biologie moléculaire de la toxoplasmose congénitale

M. H. Bessières, A. Berrebi, M. Rolland, M. C. Bloom, C. Roques et al., Neonatal screening for congenital toxoplasmosis in a cohort of 165 women infected during pregnancy and influence of in utero treatment on the results of neonatal tests, Eur J Obstet Gynecol Reprod Biol, vol.94, issue.1, pp.37-45, 2001.

M. H. Bessières, A. Berrebi, S. Cassaing, J. Fillaux, J. P. Cambus et al., Diagnosis of congenital toxoplasmosis: prenatal and neonatal evaluation of methods used in Toulouse University Hospital and incidence of congenital toxoplasmosis, Mem Inst Oswaldo Cruz, vol.104, issue.2, pp.389-92, 2009.

M. -wallon, G. Cozon, R. Ecochard, P. Lewin, and F. Peyron, Serological rebound in congenital toxoplasmosis: long-term follow-up of 133 children, Eur J Pediatr, vol.160, issue.9, pp.534-574, 2001.

B. Fortier, C. Coignard-chatain, A. Dao, V. Rouland, A. S. Valat et al., Study of developing clinical outbreak and serological rebounds in children with congenital toxoplasmosis and follow-up during the first 2 years of life

, Arch Pediatr, vol.4, issue.10, pp.940-946, 1997.

I. -jaisson-hot, M. Wallon, M. Kurdi, P. Thulliez, S. Kahi et al.,

, Presse Med, vol.30, issue.20, pp.1001-1005, 2001.

L. Lyon, Manuel Western blot IgG-IgM

C. L'olliviee, M. Walloo, B. Fauuhe, R. Piaaou, F. Peoo et al., , vol.19, pp.1326-1334, 2012.

D. Dunn and M. Wallon, Mother-to-child transmission of toxoplasmosis: risk estimates for clinical counselling, Lancet, vol.353, issue.9167, pp.1829-1862, 1999.

M. Wallon, J. Franck, P. Thulliez, C. Huissoud, F. Peyron et al., Accuracy of real time polymerase chaine reaction ofr txoxoplasma gondii in amniotic fluid, Obstet Gynecol, vol.115, pp.727-733, 2010.

J. Thomas, M. D. Garite, and A. Combs-md, Amniocentesis Obstetric issues, Labor, and Delivery, 2008.

J. Franck, Y. G. Garin, and H. Dumon, LDBio-Toxo II immunoglobulin G Western blot confirmatory test for anti-toxoplasma antibody detection, J Clin Microbiol, vol.46, issue.7, pp.2334-2342, 2008.
DOI : 10.1128/jcm.00182-08

URL : https://jcm.asm.org/content/46/7/2334.full.pdf

J. G. Koppe, D. H. Loewer-sieger, and H. De-roever-bonnet, Results of 20-year follow-up of congenital toxoplasmosis, Lancet, vol.1, pp.254-260, 1986.

F. Kieffer, M. Wallon, P. Garcia, P. Thuilliez, F. Peyron et al., Risks factors for retinochoroiditis during the first 2 years of life in infants with treated congenital toxoplasmosis, Pediatr Infect Dis. J, pp.27-32, 2008.

M. 82-cortina-borja, H. K. Tan, and M. Wallon, Prenatal treatment for serious neurological sequelae of congenital toxoplasmosis: an observational prospective cohort study, PLoS Med, vol.7, p.1000351, 2010.

C. B. Wilson, J. S. Remington, S. Stagno, and D. W. Reynolds, Development of adverse sequelae in children born with subclinical congenital Toxoplasma infection, Pediatrics, vol.66, pp.767-74, 1980.

S. A. -saxon, W. Knight, D. W. Reynolds, S. Stagno, and C. A. Alford, Intellectual deficits in children born with subclinical congenital toxoplasmosis: a preliminary report, J Pediatr, vol.82, pp.792-799, 1973.

L. Gras, M. Wallon, A. Pollak, M. Cortina-borja, B. Evengard et al., Association between prenatal treatment and clinical manifestations of congenital toxoplasmosis in infancy: A cohort study in 13 European centres, Acta Paediatr, vol.94, pp.1721-1731, 2005.

M. 86-wallon and F. Peyron, Effect of Antenatal Treatment on the Severity of Congenital Toxoplasmosis, Clin. Infect. Dis, vol.62, pp.811-812, 2016.

G. Desmonts and J. Couveur, Congenital toxoxplamosis : a prospective study of 378 pregnancies, N england Med, vol.290, pp.1110-1116, 1974.

J. Couveur, G. Desmonts, and P. Thulliez, Prophylaxis of congenital toxoplasmosis: effects of spriramycin on placental infection, J antimicrob chemother, vol.22, pp.193-200, 1988.

J. G. Montoya, Systematic screening and treatment of toxoplasmosis during pregnancy : is the glass half full or half empty, Am J Obstet Gynecol, vol.219, issue.4, pp.315-319, 2018.